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Felid herpesvirus-1 infection: influence on proinflammatory
cytokine and toll like receptor expression in vitro
Abstract
Felid herpesvirus 1 (FeHV-1) causes an acute respiratory illness known as feline rhinotrachetitis.
Moreover, it is associated with several syndromes in the feline eye including conjunctivitis, epithelial
keratitis, herpes stromal keratitis (HSK) and corneal sequestration. The aim of this study was to gain
first insights into the interaction between FeHV-1 and the feline innate immune system, specifically in
peripheral blood mononuclear cells (PBMC). FeHV-1 infection in Crandell Reese Feline Kidney cells
(CRFK) as well as in feline PBMC resulted in the induction of proinflammatory cytokine mRNA, i.e.
for Interleukin-6 (IL-6), Interleukin-1 (IL-1) and Tumor necrosis factor alpha (TNF α). To evaluate a
potential role of Toll like receptors (TLR) in the infection with FeHV-1, the level of TLR mRNA in
non-infected as well as in infected feline cells was measured. Both TLR 2 and 3 mRNA were
down-regulated in FeHV-1-infected cells. Results concerning the expression of TLR 9 mRNA were
inconsistent, showing up-regulation in some instances and down-regulation in other instances. TLR 7
was clearly up-regulated upon infection of CRFK cells with FeHV-1, not only on the mRNA level but
also in terms of function. Intriguingly, the same effect was not observed in feline PBMC. Thus, the
interaction between FeHV-1 and the innate immune system proceeds in a celltype-specific manner.  Key
words: Felid herpesvirus 1 / innate immunity / Toll like receptor.
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1. Abstract 
 
 
 
 
Felid herpesvirus 1 (FeHV-1) causes an acute respiratory illness known as feline 
rhinotrachetitis. Moreover, it is associated with several syndromes in the feline eye including 
conjunctivitis, epithelial keratitis, herpes stromal keratitis (HSK) and corneal sequestration. 
The aim of this study was to gain first insights into the interaction between FeHV-1 and the 
feline innate immune system, specifically in peripheral blood mononuclear cells (PBMC). 
FeHV-1 infection in Crandell Reese Feline Kidney cells (CRFK) as well as in feline PBMC 
resulted in the induction of proinflammatory cytokine mRNA, i.e. for Interleukin-6 (IL-6), 
Interleukin-1 (IL-1) and Tumor necrosis factor alpha (TNF α). To evaluate a potential role of 
Toll like receptors (TLR) in the infection with FeHV-1, the level of TLR mRNA in non-
infected as well as in infected feline cells was measured. Both TLR 2 and 3 mRNA were 
down-regulated in FeHV-1-infected cells. Results concerning the expression of TLR 9 mRNA 
were inconsistent, showing up-regulation in some instances and down-regulation in other 
instances. TLR 7 was clearly up-regulated upon infection of CRFK cells with FeHV-1, not 
only on the mRNA level but also in terms of function. Intriguingly, the same effect was not 
observed in feline PBMC. Thus, the interaction between FeHV-1 and the innate immune 
system proceeds in a celltype-specific manner. 
 
Key words: Felid herpesvirus 1 / innate immunity / Toll like receptor 
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2. Introduction 
2.1. Herpesviridae 
 
Herpesviruses are large, double stranded DNA viruses with an icosahedral capsid surrounded 
by a tegument layer and an envelope [34]. Today, three families build the order of 
Herpesvirales. The first family named Herpesviridae contains mammal, bird and reptile 
viruses and is further subdivided into three subfamilies, i.e. Alpha-, Beta-, and 
Gammaherpesvirinae. The second family called Alloherpesviridae includes fish and frog 
viruses, and a bivalve virus belongs to the third family Malacoherpesviridae [28].  
Infections with members of the Alphaherpesvirinae are characterized by a short and 
productive replication cycle in cell culture leading to a typical cytopathic effect [34]. 
Important members of the Alphaherpesvirinae are the herpes simplex virus type 1 (HSV-1, 
causing herpes labialis) of humans, the Bovine herpesvirus 1 (BoHV-1, causing infectious 
rhinotracheitis in cattle), the Porcine herpesvirus (Aujeszky‟s disease), and the Equine 
herpesviruses 1 and 4 (EHV-1 and EHV-4, causing respiratory disease and abortion in horses) 
[31, 66, 68, 72]. Typical for Betaherpesvirinae is a slow productive replication cycle and their 
potential to generate giant cells [34]. The Cytomegalovirus (CMV) causing CMV-pneumonia 
is a typical member of the Betaherpesvirinae. The productive replication cycle time of the 
family of the Gammaherpesvirinae is very heterogeneous. For humans Epstein-Barr-Virus 
(EBV) involved in Morbus Hodgkin and Morbus Pfeiffer disease belongs to this group [60]. 
Among the gammaherpesviruses of Veterinary interest are the Alcelaphine herpesvirus 1 
(causing bovine malignant catarrhal fever), the Equine herpesvirus 2 (EHV-2, causing 
respiratory disease and eye diseases like keratitis and conjunctivitis) and the ovine herpesvirus 
2 (OvHV-2, causing malignant catarrhal fever) [2].  
The replication of the herpesviruses takes place inside the nucleus of the infected cell [69].  
Some antigens are shared within the family of Alphaherpesvirinae, but different animal 
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species have distinct envelope glycoproteins. In general, the natural host range is highly 
restricted and most herpesviruses have evolved in association with single host species, but 
occasional transfer to other species can occur in nature [8].  
An important biological feature of herpesviruses is the establishment of lifelong persistence in 
a latent state following primary infection [63]. At the primary site of infection lytic replication 
of the virus takes place leading to the death of infected cells. Subsequently, close-by sensory 
neurons are invaded by the progeny viruses [78]. These viral particles move along the nerves 
towards sensory ganglia, in which they establish latency [64]. Typical for the latent viral 
genome is an extrachromosomal phase with only a restricted portion of genome transcription 
[69]. The latently infected cells stay intact and the virus DNA is protected from the 
immunological host response [82]. The consequences are that the infected animal is 
persistently infected and is not able to eliminate the virus. Different factors including stress 
and treatment with immunosuppressive agents can lead to a reactivation of the infection [82]. 
For the virus transmission a close contact between individuals is needed, as the virus is not 
stable in the environment [84]. In the mostly cases the first contact is often between mother 
and offspring. Because of the persistently infection and the earlier infection time point leads 
this to a wide prevalence of the virus [84]. 
2.2. Felid herpesvirus-1    
 
Felid herpesvirus 1 (FeHV-1) belongs to the family of Herpesviridae, subfamily 
Alphaherpesvirinae, genus Varicellovirus [29] and causes several syndromes in the feline eye 
including conjunctivitis, epithelial keratitis, herpes stromal keratitis (HSK) and corneal 
sequestration [61, 84]. Despite the broad distribution of feline HSK, very little is known about 
its pathogenesis and no efficient therapy is currently available [36, 92]. There is strong 
experimental evidence for an immunopathological basis of the symptoms for HSK in cats. 
The disease is characterized by the infiltration of corneal stroma by inflammatory cells, later 
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on fibrosis and vascularization can lead to blindness. One hypothesis claims that persistent 
viral antigen gains access to the stroma during periods of protracted ulceration and is 
ineffectively cleared leading to immune-mediated tissue damage [65]. This is consistent with 
a recent study by Vögtlin and others, who studied the pathogenesis of HSK in cats [90]. In the 
first stage of ocular FeHV-1 infection, high virus titers as well as high amounts of viral DNA 
were present in ocular swabs of cats with HSK, whereas no antibodies against FeHV-1 were 
yet found in their serum. The second stage showed elevated viral DNA levels combined with 
negative or low titers of infectious virus. At the same time serum antibodies against FeHV-1 
began to emerge. The third stage showed ever decreasing viral DNA levels, accompanied by 
negative virus isolation. Interestingly, keratitis occurred during the second stage of infection, 
when anti-viral antibody titers emerged, while the viral load seemed to continually decrease. 
Such a situation may be achieved by sustained proinflammatory signalling, probably through 
TLRs. 
2.3. HSK models    
 
In humans, herpes stromal keratitis (HSK) triggered by HSV-1 infection is the most common 
infectious cause of blindness in the western world and is considered to be the result of 
recurrent infection following reactivation of virus from the trigeminal ganglion [85]. Several 
models for human HSK have been established in mice [5, 20, 39, 45, 93]. Experiments using 
HSV-1 in those mouse models strongly support the hypothesis of an immunomediated 
pathogenesis [17]. Especially T cell induced inflammatory events, mainly orchestrated by 
CD4 positive cells, are thought to play an essential role [13, 30, 49]. Proinflammatory 
cytokine and chemokine production [16, 50], influx of innate immune cells, especially 
polymorphnuclear leukocytes (PMN) [27, 88, 94], and angiogenesis [12, 18, 51] represent the 
main factors which lead to the recruitment of these crucial cells and set the stage for the 
subsequent pathology. In the feline system, the origins, triggers, and molecular consequences 
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of these apparent inflammatory events are still poorly understood. Unfortunately, FeHV-1 
does not replicate in mice. Therefore, mouse models could not be established for the feline 
variant of HSK.  
2.4. Toll like receptors  
 
A major topic of immunological research is the question how the immune system is able to 
differentiate between foreign antigens and self-antigens. New insights concerning this field of 
interest have been gained in the last few years [19, 26, 45]. The mechanisms underlying the 
recognition of the pathogens early in infection by the innate immune system are of special 
interest. So called pattern recognition receptors (PRRs) were found to play an important role 
in the sensing of invading infectious agents. 
The Toll like receptors (TLRs) belong to the PRR class of molecules and are able to detect a 
broad range of pathogens [87]. First, bacteria and fungi were described to be recognized by 
TLRs. However, recent studies demonstrated the involvement of these receptors in viral 
infections [3, 15, 33, 42, 54, 75]. In addition, two genes of vaccinia virus were shown to 
influence Toll like receptor signaling indicating an important role of TLRs in antiviral defense 
[22, 40]. Distinct structures of infectious agents named pathogen-associated-molecular 
patterns (PAMPs) serve as recognition elements for the TLRs. Four types of PAMPs have 
been identified related to viruses including double stranded RNA, CpG DNA, single stranded 
RNA and envelope glycoprotein‟s (Table 1).  
Interestingly, several members of the herpesvirus family including alpha-, beta- as well as 
gammaherpesviruses were shown to be detected by different Toll like receptors [19, 25, 38, 
63, 80]. Unmethylated CpG DNA, which is present in herpesvirus genomes, depicts the 
PAMP for Toll like receptor 9 [14, 43]. The induction of inflammatory cytokines by the 
infection with various herpesviruses including HSV-1 [45, 53], HSV-2 [59] and murine 
Cytomegalovirus (MCMV) [52] was demonstrated and is supposed to rely on TLR 9. 
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Induction of antiviral immunity by TLRs in stromal and dendritic cells was demonstrated by 
Sato et al. [79]. Krug et al. [53] found that the Interferon response to HSV-1 depends on TLR 
9 and MyD88, an adaptor molecule involved in TLR signaling. Hochrein et al. described a 
TLR dependent and independent induction of IFN by HSV-1 [45]. Similarly, Lund et al. [59] 
noted that HSV-2 induced production of IFN in mouse dendritic cells through a TLR 9 
mediated pathway. In addition Tabeta and colleagues as well as Krug et al. described an 
essential role of TLR 9 in the immune defence against MCMV including cytokine responses 
and NK cell activation [52, 86]. TLR 9 is not the only member of the Toll like receptor family 
which plays a crucial role in the defense against herpesvirus infection. Jin et al. [47] described 
a TLR 7 upregulation in active and inactive HSK corneas and an implication of TLR 4, 8 and 
9 in the pathogenesis of active HSV infections. Also Li et al. [57] demonstrated an expression 
of TLR 7 in human corneal epithelial cells. In another study Li et al. [56] showed that HSV-2 
infection induces expression of TLR 7 and proinflammatory cytokines in cervical epithelial 
cells. TLR 2 as well as TLR 3 were found to be involved in cytokine signaling triggered by 
herpesviruses. Compton et al. showed that Toll like receptor 2 and CD14 recognize CMV 
virions and influence thereby cytokine release [26]. Kurt-Jones et al. demonstrated that TLR 2 
mediates the inflammatory cytokine response to HSV-1 [55]. Ashkar et al. [11] published that 
TLR 3 agonist, and not TLR 4, protects against genital herpes infection in the absence of 
inflammation seen with CpG DNA, and Tohyama et al. [89] declared the MIP-1α production 
of normal human keratinocytes in response to HSV-2 infection via TLR 3. The importance of 
an intact TLR-system was shown by Bustamante et al. [24] and Sancho-Shimizu et al. [78] 
with the description of a TLR 3 mutation and UNC93B1 impair TLR 3 response that led to a 
predisposition to herpes simplex encephalitis. Böttcher et al. [20] stated that the herpes 
simplex encephalitis caused a rise of TLR 4 mRNA. Despite the remarkable research on Toll 
like receptors and their role in recognition of pathogens in general, not much is known about 
their distribution and function in cats and the various roles of TLRs have not yet been 
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addressed in the context of infections of cats with FeHV-1. Expression of Toll like receptors 
in feline lymphoid tissue [46] and cloning of feline Toll like receptor 4 [9] is published. 
Abujamra et al. showed an interaction between the Feline Leukemia virus and Toll like 
receptor 3 [1]. Overall, it seemed that TLR 2 (recognition of virions), TLR 3 (dsRNA), TLR 4 
(LPS), TLR 7 (viral ssRNA) and TLR 9 (CpG DNA) might play an important role in the 
context of herpesvirus infections in cats. 
2.5. Aims / Hypothesis 
 
The aim of this study was to gain first insight into the interaction between Felid herpesvirus-1 
(FeHV-1) and the feline innate immune system during the first stages of infection.  
Based on experiments using HSV-1 and other herpes viruses [56, 57], we presumed a 
potential role of Toll like receptors in the pathogenesis of diseases associated with FeHV-1 
infection in cats. If this were true, the induction of proinflammatory cytokines upon infection 
of cells with FeHV-1 could be expected. However, it may be that different types of cells react 
in different ways to the FeHV-1 challenge.  
In order to test this hypothesis, the induction of proinflammatory cytokine mRNA by FeHV-1 
infection as well as the influence of FeHV-1 infection on TLR mRNA expression was 
analyzed in Crandell Reese Feline Kidney (CRFK) cells as well as in feline peripheral blood 
mononuclear cells (PBMC). As positive controls for proinflammatory cytokine induction, the 
cells were treated with the TLR 4 ligand LPS and, in one series of experiments, with 
Gardiquimod, a synthetic TLR 7 ligand.  
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3. Materials and Methods 
3.1. Cells 
 
Crandell Reese Feline Kidney (CRFK) cells and feline peripheral blood mononuclear cells 
(PBMC) were maintained in Iscove‟s modified Dulbecco‟s medium (Sigma, Buchs, 
Switzerland) supplemented with 1 % L-Glutamine (2mM) (Sigma, Buchs, Switzerland), 1 % 
Non essential amino acids (NEAA) (Invitrogen, Basel, Switzerland), 10% fetal calf serum 
(FCS) (Omnilab, Mettmenstetten, Switzerland), 5 ml Antibiotic-Antimycotic (Invitrogen, 
Basel, Switzerland) and grown at 37°C.  
3.2. Isolation of feline peripheral blood mononuclear cells  
 
EDTA blood samples from clinically healthy blood donor cats were taken and used for the 
isolation of feline peripheral blood mononuclear cells (PBMCs). Briefly, 10ml of EDTA 
blood were mixed with 10ml of ice-cold Hank`s Buffered Salt Solution (HBSS), 1 x (-) CaCl2 
(-) MgCl2 (Invitrogen, Basel, Switzerland) and 4ml of a FicollPaque™Plus (GE Healthcare, 
Zurich, Switzerland) were overlaid with 10ml of the blood/HBSS suspension. The sample was 
centrifuged at 800g, 4°C for 40 minutes and the ring containing the mononuclear cells was 
carefully removed and transferred into a new tube. Furthermore, the cells were washed twice 
with ice-cold HBSS in a total volume of 50ml. The cell pellet was suspended in cell culture 
medium and maintained as described above. 
3.3. Stimulation of cells using LPS and Gardiquimod 
 
In order to have a positive control for proinflammatory cytokine induction, PBMCs as well as 
CRFK cells were treated with 1g/ml Lipopolysaccharide (LPS) (Sigma, Buchs, 
Switzerland). To examine the response of Toll like receptor 7, cells were stimulated with the 
synthetic Toll like receptor 7 ligand Gardiquimod (Invivogen, Toulouse, France) at a 
concentration of 5g/ml. 
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3.4. Viral infections 
 
For viral infection the Felid herpesvirus 1 (FeHV-1, isolate UT88; Pharmacia, UpJohn) as 
well as a recombinant of the FeHV-1 expressing the green fluorescent protein (GFP) were 
used [77]. Stocks of UT88 and recombinant FeHV-1 used in this study were propagated on 
CRFK cells grown as described before. The titer of virus stocks was determined by standard 
TCID50 determination assay on CRFK cells using 96 well cell culture plates. Stocks were 
stored at -80°C in 1ml aliquots, and a fresh aliquot of stock virus was thawed and used for 
each experiment. As a negative control (mock) uninfected CRFK cell preparations were 
processed in the same way as virus stock preparations. To infect cells, either PBMCs or 
CRFK cell cultures were infected at low with 0,5 and high with 5 multiplicity of infection 
(moi = is the ratio of the number infections agents –virus- to infection targets –cell-) and 
grown for 1 hour at 37°C in medium containing 0% FCS. After 1 hour of adsorption, the 
inoculum was removed and cells were further cultivated at 37°C using medium including 2% 
FCS. At the indicated time, cells were processed for RNA preparation. 
 
3.5. Real – Time quantitative Polymerase chain reaction 
 
3.5.1. RNA extraction and Reverse transcription of isolated RNA into cDNA 
 
After different time points cells were harvested and total cellular RNA was isolated using the 
RNAeasy Kit (QIAgen, Basel, Switzerland) according to the manufacturer‟s protocol with 
exception of DNAse digestion, which was performed for 30min instead of 15min. The 
extracted RNA was eluted in 60l of elution buffer and concentrations as well as purity were 
determined using the NanoDrop
R
 ND 1000 spectrophotometer (Witec AG, Littau, 
Switzerland). Isolated RNA was reverse transcribed into cDNA with the Reverse 
Transcriptase Kit (Promega, Dübendorf, Switzerland) following the manufacturer‟s 
instruction. The reaction proceeded for 1 hour at 42°C and was then inactivated for 5 min at 
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95°C. The cDNA preparation was stored at -80°C and later used for quantitative Polymerase 
chain reaction analysis. 
3.5.2. Quantitative Polymerase chain reaction 
 
The reaction was performed on an iCycler IQ RealTime detection system (BioRad, Reinach, 
Switzerland). The cDNA was amplified by PCR using the specific primers listed in Table 2. 
PCR amplification was carried out in 20l reactions containing (final concentration) 10l iQ 
SYBR Green Supermix (BioRad), 1l (400nM) of each primer, 4l of cDNA (30ng) and 5l 
of sterile DEPC treated water. The conditions were set as follows: 10min 95°C, followed by 
45 cycles consisting of 15sec 95°C denaturation and 1min 60°C annealing-elongation. In 
addition a melt curve analysis was performed. Real-time data were collected and analyzed 
using the iCycler IQ Real-time Detection System Software V.3.0 (BioRad, Hercules, CA). 
Threshold cycle numbers (Ct) were transformed using the delta delta Ct methods as outlined 
in „„User Bulletin 2‟‟ provided by Applied Biosystems using GAPDH as the reference 
housekeeping gene. 
Total RNA from non-infected CRFK cells was isolated and reverse transcribed as described 
above. The amplification products for TLR 2, 3, 7, 9 and GAPDH from Real-Time PCR were 
subjected on a 2% agarose gel containing ethidiumbromide and analyzed under UV light. 
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4. Results 
4.1. Feline peripheral blood mononuclear cells are susceptible to FeHV-1 
infection 
 
In order to evaluate the potential of Felid herpesvirus 1 to infect feline peripheral blood 
mononuclear cells, a recombinant of FeHV-1 strain UT 88 expressing the green fluorescent 
protein (GFP) [77] was used. CRFK cells, which are known to be susceptible to FeHV-1 
infection, were used as a positive control. Feline peripheral blood mononuclear cells 
(PBMC‟s) and CRFK were infected at a multiplicity of infection of 5 and microscopically 
examined for expression of GFP 24 hours post infection. For this the cultures were analyzed 
under an epifluorescence microscope (Axiovert S 100, Carl Zeiss AG, Feldbach Switzerland) 
using ultraviolet and a filter for GFP [77]. In both cell types green fluorescence was detected 
indicating a successful infection (Fig.1 A and B), whereas the efficiency of infection is much 
higher in the CRFK cells as in the PBMC`s.  
4.2. FeHV-1 infection leads to proinflammatory cytokine induction  
 
To gain a more detailed picture of the first stadium of infection with FeHV-1 and its 
consequence on innate immune responses, the induction of proinflammatory cytokine mRNA 
was measured. As a positive control, the expression of the proinflammatory cytokine 
Interleukin-6 (IL-6) mRNA was determined using feline PBMCs treated with 
Lipopolysaccharide (LPS). Indeed, LPS treatment strongly induced IL-6 mRNA synthesis in 
PBMCs at 24h post stimulation. The results from unstimulated and LPS-stimulated, 
respectively, PBMCs of three individual cats are shown in the Figure (Fig.2 A). Furthermore, 
CRFK cells were treated with LPS in order to evaluate their potential over 4h to produce a 
proinflammatory cytokine response. As shown in Figure 2B the ability of CRFK cells to 
produce IL-6 mRNA upon LPS stimulation was clearly demonstrated. In a second step, feline 
PBMCs and CRFK cells were infected with the wild-type FeHV-1 strain UT88 using a moi of 
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5. At different time points post infection, cells were harvested and analyzed for IL-6 mRNA 
expression by quantitative RT-PCR. An up-regulation of IL-6 mRNA level was found in 
PBMCs (Fig. 3A) as well as in CRFK cells (Fig. 3B) which were infected at different moi and 
assessed 24 hours post infection. Furthermore, the induction of the two other proinflammatory 
cytokine mRNAs - Interleukin-1 (IL-1) and Tumor necrosis factor alpha (TNF) - was 
demonstrated (Fig. 4A and B). 
Taken together, these results clearly indicate the ability of FeHV-1 to induce a 
proinflammatory cytokine response in vitro. 
4.3. Expression of Toll like receptor mRNAs in non-infected PBMCs and 
CRFK cells 
 
To form functional Toll like receptors, TLR-specific mRNAs must first be expressed in a 
given cell. Therefore, in a first step the mRNA expression of feline TLRs in non-infected 
PBMCs and CRFK cells was analyzed. Since several TLRs, including 2, 3, 7 and 9 have been 
suggested to be involved in the recognition of HSV-1 infection or other viral infections, these 
specific TLRs were focused on. The expression of mRNAs for all these receptors in both 
PBMCs (data not shown) as well as in CRFK (Fig.5) was determined by RT-PCR. As an 
internal control for RNA extraction and RT-PCR, the expression of the house-keeping gene 
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used. 
4.4. Expression of Toll like receptor mRNAs in FeHV-1 infected CRFK cells 
 
Having shown the presence of TLR 2, 3, 7 and 9 mRNA in feline cells, the influence of 
FeHV-1 infection on the expression of these TLRs was studied. Therefore, CRFK cells were 
either infected or mock treated and after various time points the TLR mRNA levels were 
determined using qRT-PCR. Experiments concerning the expression of TLR 2, 3 and 7 
mRNA were consistent and are shown in Figure 6. Interestingly, TLR 7 mRNA was up-
regulated, visible in Figure 6C 12 hours post infection and in Figure 6D 36 hours post 
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infection, whereas TLR 2 and TLR 3 mRNA expressions were down-regulated, visible 5 
hours post infection. In contrast, results regarding the level of TLR 9 mRNA expression 
following FeHV-1 infection were not consistent. In some experiments an up-regulation of 
TLR 9 mRNA was detected in others a down-regulation was observed (data not shown).  
4.5. Stimulation of FeHV-1 infected CRFK cells with the TLR 7 agonist 
Gardiquimod 
 
Having demonstrated an up-regulation of Toll like receptor 7 mRNA in FeHV-1 infected 
CRFK cells, the ability of infected and non-infected cells to respond to the TLR 7 agonist 
Gardiquimod, which mimics double-stranded RNA, was further investigated. Since a 
tremendous up-regulation of TLR 7 mRNA level was shown at 36 hours post infection, 
infected and mock treated cells were stimulated with Gardiquimod at this time point. As 
readout for TLR 7 stimulation IL-1 (Fig. 7A) as well as TNF (Fig. 7B) mRNA expression 
were measured at 0, 4, 6 and 8 hours post stimulation. FeHV-1 infected cells were shown to 
produce significantly higher levels of proinflammatory cytokine mRNAs in response to 
Gardiquimod compared to mock treated cells. In Figure 7C the course of TLR 7 mRNA at 0, 
4, 6, and 8 hours post stimulation with Gardiquimod is shown. 
4.6. Stimulation of FeHV-1 infected PBMCs with the TLR 7 agonist 
Gardiquimod 
 
After having shown a higher proinflammatory cytokine response to the TLR 7 agonist 
Gardiquimod of FeHV-1 infected CRFK cells compared to mock treated cells the reaction of 
FeHV-1 infected PBMCs to Gardiquimod was examined. As described in the previous 
section, FeHV-1 infected and mock treated PBMCs were stimulated with Gardiquimod 36 
hours post infection. In contrast to the experiments with CRFK cells, the infection was 
performed using either moi 0.5 (Fig. 8A - 8C) or moi 5 (Fig. 8D – 8F). As readout of TLR 7 
stimulation IL-1 (Fig. 8A, 8D) as well as TNF  (Fig. 8B, 8E) mRNA expression were 
measured 0, 4, 6 and 8 hours post stimulation with Gardiquimod. In addition, the mRNA 
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levels of TLR 7 (Fig. 8C, 8F) were measured at 0, 4, 6 and 8 hours post stimulation. In none 
of the experiments a significant difference between mock and FeHV-1 infected PBMCs with 
respect to cytokine production following Gardiquimod stimulation was observed.  
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5. Discussion 
 
The interaction of FeHV-1 with its host, the cat, is poorly understood, particularly in the 
initial stage of infection. The aim of our study was to gain first insights into the interaction of 
FeHV-1 with the feline innate immune system. The prerequisite of these experiments was the 
availability of susceptible cells, which are able to elicit a proinflammatory cytokine response. 
First, we demonstrated that feline PBMC`s are susceptible to FeHV-1 infection using a 
recombinant FeHV-1 virus expressing the green fluorescent protein (GFP) [77]. This result is 
in accordance with a report by Palmer et al. [67], who described the infection of human 
PBMC‟s with HSV-1 and the following induction of IFN-α and IFN-β mRNA in these cells. 
In addition, we showed evidence for the induction of proinflammatory cytokines in feline 
PBMC‟s and CRFK cells 24 hours post infection with FeHV-1, i.e a significant up-regulation 
of IL-6 as well as the induction of two other proinflammatory cytokines, IL-1 and TNF, 
which were shown at various time points post infection. The up-regulation of the cytokine 
mRNAs reached a maximum between 24 and 36 hours post infection.  
Our results are in accordance with the finding of enhanced nasal cytokine transcription in 
FeHV-1 infected cats [48]. In addition experiments using Herpes simplex virus type 1 showed 
the induction of proinflammatory cytokines in vitro [57]. Aravalli et al. [7] demonstrated 
proinflammatory cytokine and chemokine production by murine microglial cells in response 
to HSV-1, as well as increased TNF-α and IL-6 mRNA through HSV-1 infection. 
Interestingly, Hayashi et al. [41] showed in their experiments an IL-6 release from infected 
corneal cells in humans. 
Toll like receptors (TLRs) are involved in cytokine production in response to viral infections 
[26, 45, 52, 53, 58, 63, 81, 91]. We were able to demonstrate the expression of TLR 2, 3, 7 
and 9 in non-infected CRFK cells and feline PBMC‟s. So far, TLR 2, 3, 7 and 9 were shown 
to be involved in the recognition of Herpes simplex virus 1 [4, 10, 32, 39, 70, 77]. 
Furthermore, we examined a potential influence of FeHV-1 infection on the expression of 
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feline Toll like receptors. Interestingly, we could show that infection of CRFK cells with 
FeHV-1 did not have the same effect on various members of the TLR family. TLR 2 as well 
as TLR 3 were shown to be down-regulated with a maximum of down-regulation at 5 hours 
post infection. In contrast, we found evidence that the expression of TLR 7 was up-regulated 
with a maximum at 36 hours post infection. These results are in accordance with a study using 
HSV-1 infected human corneal epithelial cells, in which a down-regulation of TLR 3 as well 
as an induction of TLR 7 could be demonstrated [57].  Jin et al. [47] described that all TLRs 
expressed diversely in the healthy cornea. TLR 4, 8 and 9 may be implicated in the 
pathogenesis of active HSV-1 infection in the cornea, whereas TLR 7 may play a key role in 
HSK whether it is active or not, since it was the only TLR which was up-regulated during the 
phase of virus persistence in ganglia without clinical symptoms in the eye. TLR 2, 3, 4, 5, 6, 
8, 9 and 10 were down-regulated to this time. 
Interestingly, the results for TLR 9 expression in our experimental set up were contradictory 
in each performed experiment. In contrast, earlier results described a TLR 2, 3 and TLR 9 up-
regulation during HSV-1 infections in humans [93].  
One possible explanation for this phenomenon, showing results contradictory to the published 
literature, could be based on the cell types used for the experiments [57]. It would be of 
interest to repeat the experiments using our experimental set up with feline corneal cells to 
address the question, whether or not it is the used cell type which leads to the different results 
regarding TLR 2, 3 and 9 expressions.  
From the described results, we conclude that the infection with FeHV-1 appears to have a 
different impact on TLR expression depending on the type of receptor. Since TLR 7 was 
shown to be up-regulated by the infection with FeHV-1, we were interested in the reactivity 
of infected cells to a specific TLR 7 agonist. In order to address this question, we infected 
CRFK cells and treated them 36 hours post infection with the specific TLR 7 ligand 
Gardiquimod. The expression of IL-1 and TNF following stimulation with Gardiquimod was 
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higher in FeHV-1 infected cells compared to mock treated cells. This result leads to the 
conclusion that FeHV-1 infection leads to an up-regulation of TLR 7 and as a consequence to 
an increased responsiveness of infected cells to the TLR 7 agonist Gardiquimod.  
In contrast to the experiments using CRFK cells, such an effect could not be demonstrated in 
feline PBMCs. The induction of proinflammatory cytokines in FeHV-1 infected and mock 
treated PBMCs following stimulation with the TLR 7 agonist Gardiquimod did not differ.  
A possible explanation for this can be the different infection level between CRFK cells and 
PBMC`s as demonstrated in Figure 1A and 1B. Using the recombinant eGFP expressing 
FeHV-1 the number of fluorescent cells was higher in cultured CRFK cells than in freshly 
isolated PBMCs. Therefore, the number of cells contributing to the effect is lower in the case 
of PBMC`s. However, the effect could also be based on the different cell type. To further 
study the effect of FeHV-1 infection on PBMCs, it would be valuable to separate the infected 
from the non-infected PBMCs by FACS in order to look at homogenous cell populations. 
 
In summary, we demonstrate in this work the induction of proinflammatory cytokine mRNA 
by FeHV-1 infection in CRFK cells as well as in feline PBMCs. In addition, up-regulated 
mRNA expression and activity of Toll like receptor 7 in FeHV-1 infected CRFK cells were 
shown.  
The experiments described in this study show an influence on proinflammatory cytokine and 
TLR expression in FeHV-1 disease. Furthermore, having more knowledge about TLR 
expression and function in the cat will open the door for future investigations of pathogen-
host interactions in feline virology. Moreover, detailed studies about TLR induced signaling 
by FeHV-1 could lead to the development of novel therapeutic strategies [5, 21, 23, 44]. 
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7. Figure legends, Tables and Figures  
 
Figure 1 
Infection of feline cells with a recombinant FeHV-1 expressing eGFP. Feline PBMCs (A) and 
CRFK cells (B) were infected with moi 5 and microscopic pictures were taken 24 hrs post 
infection.  
 
Figure 2 
IL-6 mRNA expression of cells treated with 1µg/ml LPS measured by qRT-PCR. (A) IL-6 
mRNA levels in PBMCs isolated from three individual cats at 24h after mock-treatment or 
LPS-stimulation. (B) IL-6 mRNA levels at 0, 2, and 4h after mock- or LPS-stimulation in 
CRFK cells. The Error Bars of (B) were calculated on the basis of 3 experiments. 
 
Figure 3 
IL-6 mRNA expression of wt FeHV-1 infected cells measured by qRT-PCR. PBMCs (A) or 
CRFK cells (B) were infected at different moi and IL-6 mRNA levels were assessed 24h post 
infection. The Error Bars of (B) were calculated on the basis of 3 experiments. 
 
Figure 4 
Proinflammatory cytokine expression in wt FeHV-1 infected (moi 5) CRFK cells measured 
by qRT-PCR. IL-1 (A) and TNF (B) mRNA expression of CRFK cells 0, 6, 12, 24, and 36h 
post infection was determined. The Error Bars here were calculated on the basis of 3 
experiments. 
 
Figure 5 
Agarose gel electrophoresis of Toll like receptor specific RT-PCR amplimers in non-infected 
CRFK cells. 
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Figure 6 
Toll like receptor expression in wt FeHV-1infected CRFK cells measured by qRT-PCR. 
CRFK cells were infected with wt FeHV-1 at moi 5 and TLR 2 (A), TLR 3 (B) and TLR 7 (C, 
D) mRNA expression were assessed at different time points post infection. The Error Bars of 
(A) and (B) were calculated on the basis of 4 experiments and (C) and (D) on 3 experiments. 
 
Figure 7 
Proinflammatory cytokine and TLR 7 mRNA expression in CRFK cells treated with 
Gardiquimod. Mock or with wt FeHV-1 (moi 5) infected CRFK cells were stimulated with 
5µg/ml Gardiquimod 36h post infection. 0, 4, 6, 8h post stimulation IL-1 (A), TNF (B) as 
well as TLR 7 (C) mRNA expression was determined. The Error Bars here were calculated on 
the basis of 3 experiments. 
 
Figure 8 
Proinflammatory cytokine and TLR 7 mRNA expression in PBMCs treated with 
Gardiquimod. Mock or with wt FeHV-1, moi 0,5 (A),(B) and (C) and moi 5 (D), (E) and (F), 
infected PBMCs were stimulated with 5µg/ml Gardiquimod 36h post infection. 0, 4, 6, 8h 
post stimulation IL-1 (A) and (D), TNF (B) and (E) as well as TLR 7 (C) and (F) mRNA 
expression was determined. The Error Bars here were calculated on the basis of 3 
experiments. 
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Table 1. Toll like receptors and their Pathogen Associated Molecular Patterns (PAMPs) 
 
Toll like receptor PAMP Agonist Pathogen 
TLR 2 Peptidoglycan, 
lipopeptides, atypical LPS 
(bacteria) 
 Measles virus hemagglutinin protein 
Herpes simplex virus (HSV-1) 
Human cytomegalovirus 
Zymosan, 
phospholipomannan 
(fungi) 
GPI anchor (protozoa) 
Envelope protein (virus) 
TLR 3 Poly (I:C), dsRNA (virus)  Poly (I:C) 
Murine cytomegalovirus (MCMV) 
Vesicular stomatitis virus (VSV) 
Lymphocytic choriomeningitis virus  
Reovirus 
West Nile virus 
TLR 4 LPS (bacteria)  Mouse mammary tumor virus envelope 
protein 
Respiratory syncytial virus 
Mannan, 
glucuronoxylomannan 
(fungi) 
Glycoinositolphospholipids 
(protozoa) 
RSV fusion protein (virus) 
TLR 7 / TLR 8 Synthetic 
imidazoquinoline-like 
molecules, ssRNA (virus) 
Gardiquimod R848 
Imiquimod 
Loxoribine 
Human immunodeficiency virus 
VSV 
Influenza virus 
Feline papillomavirus 
TLR 9 GpG DNA (bacteria, 
protozoa, virus), dsDNA 
 HSV-1 
HSV-2 
MCMV 
Synthetic CpG DNA 
Hemozoin (protozoa) 
(State-of-the-art of Immunology) 
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Table 2. Feline specific primer sequences for Real-time PCR 
Primer name Sequence in 5’-3’ orientation Reference 
GAPDH forward GCCGTGGAATTTGCCGT [35] 
GAPDH reverse GCCATCAATGACCCCTTCAT [35] 
IL-1 forward AATGACCTGTTCTTTGAGGCTGAT [35] 
IL-1 reverse CCAGAAAACTGTGGCTCAGGTT [35] 
IL-6 forward CCCTGCAGACAAAATGGAAGA [35] 
IL-6 reverse GTGCCTCCTTGCTGTCCTCA [35] 
TNF α forward CTTCTCGAACTCCGAGTGACAAG [35] 
TNF α reverse CCACTGGAGTTGCCCTTCA [35] 
TLR 2 forward AGACTCTACCAGATGCCTCCTTCT [46] 
TLR 2 reverse GCGTGAAAGACAGGAATTCACAGG [46] 
TLR 3 forward CAACAACTTAGCACGGCTATGG GenBank Accession Nr. DQ266436 
(Felis catus Toll-like receptor 3 (TLR3) 
mRNA, complete cds) 
TLR 3 reverse AATGTGGAGGTGAGAAAGACCC GenBank Accession Nr. DQ266436 
(Felis catus Toll-like receptor 3 (TLR3) 
mRNA, complete cds) 
TLR 7 forward AATCGGTTTCTGTGCACCTGT GenBank Accession Nr. DQ333223 
(Felis catus Toll-like receptor 7 (TLR7) 
mRNA, complete cds) 
TLR 7 reverse GCCAAGTAAGGAATAGTCACCTCTG GenBank Accession Nr. DQ333223 
(Felis catus Toll-like receptor 7 (TLR7) 
mRNA, complete cds) 
TLR 9 forward GGACCTGAGTGAGAACTTCCTATATGAC GenBank Accession Nr. AY859724 
(Felis catus Toll-like receptor 9 (TLR9) 
mRNA, complete cds) 
TLR 9 reverse GGTAATTGAAAGACAAGTTGAGTCTGC GenBank Accession Nr. AY859724 
(Felis catus Toll-like receptor 9 (TLR9) 
mRNA, complete cds) 
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Figure 2 B 
 
 
 
Figure 3 A 
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Figure 3 B 
 
 
 
Figure 4 A 
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Figure 4 B 
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Figure 6 A  
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Figure 6 C 
 
 
Figure 6 D 
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Figure 7 A 
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Figure 7 C 
 
 
Figure 8 A 
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Figure 8 B 
 
 
Figure 8 C 
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Figure 8 D 
 
 
Figure 8 E 
0.0
0.2
0.4
0.6
0.8
1.0
1.2
0 hour 4 hours 6 hours 8 hours
IL
-1
 m
N
A
 l
e
v
e
ls
time post stimulation
Mock Virus
0
2
4
6
8
10
12
14
0 hour 4 hours 6 hours 8 hours
T
N
F
 
m
R
N
A
 l
e
v
e
ls
time post stimulation
Mock Virus
43 
 
 
Figure 8 F 
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